Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06281210

Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

Led by European Institute of Oncology · Updated on 2024-02-28

77

Participants Needed

2

Research Sites

263 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This single arm study aims to evaluate the efficacy and safety of a non-surgical approach, consisting of radiotherapy (RT) alone, for patients who have achieved a complete pathological response (pCR) following neoadjuvant chemotherapy (NACT). The study design involves the histological confirmation of pCR using vacuum-assisted biopsy (VABB) or vacuum-assisted excision (VAE) guided by ultrasound. The primary objective is to demonstrate that the non-surgical, RT-only treatment and follow-up approach is not inferior to the traditional surgical approach in patients with pCR after NACT.

CONDITIONS

Official Title

Vabb After Neoadjuvant Therapy to Avoid Surgery-pCR to Avoid Breast Surgery

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age greater than 18 years
  • Diagnosed with infiltrating breast carcinoma, non-special histotype, triple negative or HER2-positive, stage T1-T2 N0
  • Presence of a single lesion
  • Completed at least 12 weeks of neoadjuvant chemotherapy according to clinical practice
  • Eligible for conservative surgery
  • No distant metastasis (M0)
  • Tumor bed identified by breast markers placed before neoadjuvant chemotherapy by a radiologist
Not Eligible

You will not qualify if you...

  • Bilateral or multicentric tumor
  • Presence of microcalcifications seen on mammography
  • Presence of associated ductal carcinoma in situ (DCIS)
  • History of previous breast cancer
  • History of medical or psychiatric conditions that prevent adherence to the study protocol
  • Classified as a high-risk patient

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Istituto di Candiolo IRCCS

Candiolo, Turin, Italy, 10060

Not Yet Recruiting

2

European Institute of Oncology

Milan, Italy, 20141

Actively Recruiting

Loading map...

Research Team

E

Elisabetta Rossi, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here